Support Burnet’s COVID-19 emergency response
COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
One potential impact of the roll-out of malaria interventions, including mass drug administration (MDA), is malaria rebound after elimination which is thought to be due to the loss of naturally acquired malaria immunity. However, the timelines for this is unknown and is required in order to inform appropriate malaria interventions and surveillance strategies.
Utilising data from malaria intervention trials in the Greater Mekong region, we seek to quantify the impact of malaria control measures including MDA (and therefore potential elimination) on malaria immunity within communities and how this predicts epidemiological patterns of disease over time.
Jan 2015 – Feb 2023
NHMRC
For any general enquiries relating to this project, please contact:
Deputy Program Director, Maternal and Child Health
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2020 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.
